PEMPHIGUS VULGARIS
Clinical trials for PEMPHIGUS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS VULGARIS trials appear
Sign up with your email to follow new studies for PEMPHIGUS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target cause of painful blistering disease
Disease control Recruiting nowThis study is testing two new cell therapies for adults with active pemphigus vulgaris, a painful autoimmune disease that causes severe blisters. Researchers are giving patients their own immune cells that have been specially engineered in a lab to target and potentially control …
Matched conditions: PEMPHIGUS VULGARIS
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Researchers seek better tools to track rare skin diseases
Knowledge-focused Recruiting nowThis study aims to better understand and measure the severity of autoimmune blistering diseases like pemphigus and bullous pemphigoid. Researchers will collect data from 150 adult patients to compare different scoring systems and assess how these conditions affect quality of life…
Matched conditions: PEMPHIGUS VULGARIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Apr 02, 2026 04:12 UTC